Left Ventricular Mass Change After Anthracycline Chemotherapy [Emerging Investigators]

Conclusions:
Early after Anth-bC, LV mass reductions associate with worsening HF symptomatology independent of LVEF. These data suggest an alternative mechanism whereby anthracyclines may contribute to HF symptomatology and raise the possibility that surveillance strategies during Anth-bC should also assess LV mass.

Source: Circulation: Heart Failure - July 10, 2018 Category: Cardiology Authors: Jordan, J. H., Castellino, S. M., Melendez, G. C., Klepin, H. D., Ellis, L. R., Lamar, Z., Vasu, S., Kitzman, D. W., Ntim, W. O., Brubaker, P. H., Reichek, N., DAgostino, R. B., Hundley, W. G. Tags: Cardiomyopathy, Heart Failure, Remodeling, Magnetic Resonance Imaging (MRI) Emerging Investigators Source Type: research